Lessee, Operating Lease, Liability, to be Paid, Year One in USD of Inmune Bio, Inc. from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Inmune Bio, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and change rate from Q2 2019 to Q3 2025.
  • Inmune Bio, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 30 Sep 2025 was $729K.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)

Inmune Bio, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $729K 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $278K +$86K +44.8% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $198K +$6K +3.13% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $193K +$7K +3.76% 31 Dec 2024 10-K 27 Mar 2025
Q2 2024 $192K 30 Jun 2024 10-Q 01 Aug 2024
Q1 2024 $192K 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $186K 31 Dec 2023 10-K 28 Mar 2024
Q4 2021 $192K 31 Dec 2021 10-Q 31 Oct 2024
Q2 2019 $0 30 Jun 2019 10-Q 09 Aug 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.